In #DrugDevelopment , we don’t always know what we don’t know, but what’s guaranteed is that there’s something. #OncTwitter

#HemeSeries : w/Nitin Jain we🗣️SoC for #CLL

- Fixed Rx vs BTKi
- Acala vs Zanu?
- Pirtobrutinib ✅

Full discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/cll-algo-2024
- Also on the “Oncology Brothers” podcast

#Leusm #HemeTwitter #MedTwitter #OncTwitter CancerNetwork®

#HemeSeries : This is the #Algorithm we have used during our discussion w/ Nitin Jain for #CLL

#HemeTwitter #OncTwitter #MedTwtitter #leusm #MedEd CancerNetwork® #OncEd OncoAlert Hem-Onc Fellows Network

Lung cancer can happen to anyone! Even 38 year old Stephanie, who had no risk factors! #cancer #lcsm #medtwitter #onctwitter #younglungcancer #ylci

Technology is amazing.
#BreastCancer #OncTwitter #MedTwitter
news.mit.edu/2023/wearable-…

New Review - Napolitano et al - Targeting the EGFR signalling pathway in metastatic colorectal cancer

thelancet.com/journals/langa…

#CRCSM #OncTwitter #GITwitter

Don't miss the #TAPUR Study Virtual Grand Rounds on May 6. This is your chance to learn about our ongoing #TAPUR Study #ClinicalTrial . Expert speakers include Richard Schilsky, Janet Freeman-Daily & Dr. Jens Rueter. Register ➡️ brnw.ch/21wJhvQ #OncTwitter #PrecisionMedicine

#GISeries : Here we🗣️about the U.S. FDA approval of #Fruquintinib from #FRESCO2 & how it fits in our Rx paradigm w/Arvind Dasari, MD, MS

Full Int:
- targetedonc.com/pivotal-practi…
- oncbrothers.com/JC-FRESCO2
- Also on the “Oncology Brothers” podcast

#OncTwitter #MedTwitter Targeted Oncology #crcsm

Based on results from the phase 3 innovaTV 301 trial, the U.S. FDA approved tisotumab vedotin for patients with recurrent/metastatic cervical cancer who experienced disease progression on/after systemic treatment. Learn more: hmpgloballearningnetwork.com/site/onc/news/…

#medtwitter #onctwitter

We’re looking forward to #ASCO24 where we’ll present updated Phase 1/2 data and explain how we’re using advanced #AI to harness the power of IL-2 with our novel monoclonal antibody, #AU007 .

If you’re in #Chicago , come by our poster presentation ASCO!

#OncTwitter #MedEd

📌 #Pheochromocytoma and #paraganglioma can be easily misdiagnosed with common conditions.
👉We help clinicians to consider NETs with #NETInfo in 11 languages: incalliance.org/net-info-packs/ #LetsTalkAboutNETs #MedTwitter #EndoTwitter #MedEd #OncTwitter

Check out PeerView's #SCLC activity! Drs. Taofeek K. Owonikoko (Taofeek K Owonikoko), Anne Chiang (@AnneChiangMD), & Jared Weiss (@DrJaredWeiss) discuss the nuances of current and emerging therapies. bit.ly/47MGmO3 #LungCancer #Oncology #OncTwitter #MedEd #MedTwitter #TTLC24

#RenalCancer and #ThyroidCancer rates are 16% and 10% higher, respectively, in patients with #AgeRelatedMacularDegeneration (AMD). Research in the Ophthalmology at BMJ

Read here: brnw.ch/21wJ94B

#OncTwitter #NerveTumors #SkinCancer #StomachCancer #Ophthalmology #MedTwitter

Omitir la cirugía axilar en pacientes con cáncer de mama temprano y metástasis en el ganglio centinela con cirugía y radioterapia no afectó a la supervivencia. #cancer #OncTwitter
ms.spr.ly/6012Y3NCs

According to Toni Choueiri, MD and coauthors, 'Adjuvant pembrolizumab was associated with a significant and clinically meaningful improvement in overall survival, as compared with placebo.' Learn more: hmpgloballearningnetwork.com/site/onc/news/…

#medtwitter #onctwitter

Interested in mentoring the next generation of oncologists at #ASCO24 ? Be a situational mentor and participate in our Career Conversation meetings that connect attendees w/ more experienced oncology professionals.

Sign up by 5/3: brnw.ch/21wJbkm #OncTwitter

New The Lancet Reg Health-Europe - major disparities in use of gFOBT, FIT, and colonoscopy for colorectal cancer screening across European countries

thelancet.com/journals/lanep…

#CRCSM #OncTwitter #GITwitter OncoAlert

Chronic #OcularSurface Inflammation may be a risk factor for the development of #OcularSurface SquamousNeoplasia (OSSN). Published in the journal Ocular Surface.

Read here: brnw.ch/21wJb7K

#OcularSurface #OSSN #ChronicInflammation #OncTwitter #Ophthalmology #MedTwitter

At #GDULC Jamie Chaft, MD, argued in favor of perioperative immunotherapy in the treatment of lung cancer. Learn more: hmpgloballearningnetwork.com/site/onc/confe…

#medtwitter #onctwitter

Pancreatic NET can be easily missed due to common symptoms.
👉We help clinicians to mind the zebra with #NETInfo in 11 languages: incalliance.org/net-info-packs/
#LetsTalkAboutNETs #MedTwitter #GITwitter #RadTwitter #EndoTwitter #MedEd #OncTwitter